Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresistance is the primary reason for the unfavourable prognosis of HGSOC. Kallistatin (KAL), also...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huan, Li, Rongrong, Zhang, Zhiwei, Jiang, Huiyang, Ma, Hanlin, Yuan, Cunzhong, Sun, Chenggong, Li, Yingwei, Kong, Beihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935502/
https://www.ncbi.nlm.nih.gov/pubmed/31884974
http://dx.doi.org/10.1186/s13048-019-0601-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935502/
https://www.ncbi.nlm.nih.gov/pubmed/31884974
http://dx.doi.org/10.1186/s13048-019-0601-6

Ejemplares similares